Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group.
Saved in:
| Title: | Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. |
|---|---|
| Authors: | Ramia de Cap, Maximiliano1,2,3 (AUTHOR), Wu, Leo P.1,2 (AUTHOR), Hirt, Christian1,2 (AUTHOR), Pihan, German A.1,2 (AUTHOR), Patel, Sanjay S.4 (AUTHOR), Tam, Wayne4 (AUTHOR), Bueso-Ramos, Carlos E.5 (AUTHOR), Kanagal-Shamanna, Rashmi5 (AUTHOR), Raess, Philipp W.6 (AUTHOR), Siddon, Alexa7 (AUTHOR), Narayanan, Damodaran1,8 (AUTHOR), Morgan, Elizabeth A.1,8 (AUTHOR), Pinkus, Geraldine S.1,8 (AUTHOR), Mason, Emily F.9 (AUTHOR), Hsi, Eric D.10 (AUTHOR), Rogers, Heesun J.11 (AUTHOR), Toth, Laura12 (AUTHOR), Foucar, Kathryn12 (AUTHOR), Hurwitz, Stephanie N.13 (AUTHOR), Bagg, Adam13 (AUTHOR) |
| Source: | Leukemia & Lymphoma. May2023, Vol. 64 Issue 5, p972-980. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
